Profile change history

What changed for Icatibant?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Icatibant identity.

64Total events
64Record additions
0Version changes
15Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 64 connected records →

Showing the latest 64 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00097695

PeptideScanner retained ClinicalTrials.gov record NCT00097695 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 9, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00223704

PeptideScanner retained ClinicalTrials.gov record NCT00223704 at 2026-11-15T22:04:12.435Z. Its registry update date was 2013-11-25, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
November 25, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00500656

PeptideScanner retained ClinicalTrials.gov record NCT00500656 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 9, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00912093

PeptideScanner retained ClinicalTrials.gov record NCT00912093 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-11, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 11, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00997204

PeptideScanner retained ClinicalTrials.gov record NCT00997204 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-11, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 11, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01386658

PeptideScanner retained ClinicalTrials.gov record NCT01386658 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-08, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 8, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01457430

PeptideScanner retained ClinicalTrials.gov record NCT01457430 at 2026-11-15T22:04:12.435Z. Its registry update date was 2016-10-18, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
October 18, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01919801

PeptideScanner retained ClinicalTrials.gov record NCT01919801 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-08, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 8, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02045264

PeptideScanner retained ClinicalTrials.gov record NCT02045264 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-03, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 3, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03177798

PeptideScanner retained ClinicalTrials.gov record NCT03177798 at 2026-11-15T22:04:12.435Z. Its registry update date was 2019-10-29, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
October 29, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03888755

PeptideScanner retained ClinicalTrials.gov record NCT03888755 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-03, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
June 3, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04057131

PeptideScanner retained ClinicalTrials.gov record NCT04057131 at 2026-11-15T22:04:12.435Z. Its registry update date was 2025-02-21, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
February 21, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04113109

PeptideScanner retained ClinicalTrials.gov record NCT04113109 at 2026-11-15T22:04:12.435Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
August 11, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04488081

PeptideScanner retained ClinicalTrials.gov record NCT04488081 at 2026-11-15T22:04:12.435Z. Its registry update date was 2026-03-16, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
March 16, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04654351

PeptideScanner retained ClinicalTrials.gov record NCT04654351 at 2026-11-15T22:04:12.435Z. Its registry update date was 2022-03-29, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
March 29, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04978051

PeptideScanner retained ClinicalTrials.gov record NCT04978051 at 2026-11-15T22:04:12.435Z. Its registry update date was 2022-08-03, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
August 3, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05407597

PeptideScanner retained ClinicalTrials.gov record NCT05407597 at 2026-11-15T22:04:12.435Z. Its registry update date was 2023-09-07, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
September 7, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05509569

PeptideScanner retained ClinicalTrials.gov record NCT05509569 at 2026-11-15T22:04:12.435Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
August 7, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05834777

PeptideScanner retained ClinicalTrials.gov record NCT05834777 at 2026-11-15T22:04:12.435Z. Its registry update date was 2026-10-22, and PeptideScanner's reviewed identity mapping was icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
October 22, 2026
Evidence lane
Clinical trials
Record added

Federal Register notice 2011-12543

The Federal Register published notice 2011-12543, attributed to FDA and its parent HHS department, on 2011-05-23. Its official title is “Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
May 23, 2011
Evidence lane
Regulatory
Record added

Federal Register notice 2014-07331

The Federal Register published notice 2014-07331, attributed to FDA and its parent HHS department, on 2014-04-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FIRAZYR,” and PeptideScanner's exact reviewed identity mapping connects the document to Icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
April 2, 2014
Evidence lane
Regulatory
Record added

Federal Register notice 2023-04175

The Federal Register published notice 2023-04175, attributed to FDA and its parent HHS department, on 2023-03-01. Its official title is “Mylan Pharmaceuticals Inc., et.al.; Withdrawal of Approval of 11 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
March 1, 2023
Evidence lane
Regulatory
Record added

Federal Register notice E7-24812

The Federal Register published notice E7-24812, attributed to FDA and its parent HHS department, on 2007-12-21. Its official title is “Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Icatibant.

PeptideScanner change date
November 15, 2026
Cited source date
December 21, 2007
Evidence lane
Regulatory
Record added

Icatibant: HOE 140, JE 049, JE049.

PubMed lists PMID 15563238 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 25, 2018
Evidence lane
Literature metadata
Record added

Icatibant: HOE 140, JE 049, JE049.

PubMed lists PMID 15991885 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2005 (year precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 25, 2018
Evidence lane
Literature metadata
Record added

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

PubMed lists PMID 17418383 in The Journal of allergy and clinical immunology as Clinical Trial, Phase I, Journal Article, with publication-date metadata of 2007-04-05 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 20, 2014
Evidence lane
Literature metadata
Record added

Icatibant for hereditary angioedema.

PubMed lists PMID 20135020 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2009-12 (month precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 22, 2025
Evidence lane
Literature metadata
Record added

Icatibant in hereditary angioedema: news and challenges.

PubMed lists PMID 21595592 in Expert review of clinical immunology as Journal Article, Review, with publication-date metadata of 2011-05 (month precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of adult patients with icatibant in hereditary angioedema.

PubMed lists PMID 21788245 in Emergency medicine journal : EMJ as Journal Article, Review, with publication-date metadata of 2011-08 (month precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.

PubMed lists PMID 22970904 in Expert opinion on pharmacotherapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2012-09-13 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 30, 2022
Evidence lane
Literature metadata
Record added

Icatibant for the treatment of hereditary angioedema.

PubMed lists PMID 23249729 in The Annals of pharmacotherapy as Comparative Study, Journal Article, Review, with publication-date metadata of 2012-12-18 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 16, 2017
Evidence lane
Literature metadata
Record added

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

PubMed lists PMID 24749847 in Clinical and experimental immunology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, and 1 more PubMed publication type, with publication-date metadata of 2014-08 (month precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 8, 2026
Evidence lane
Literature metadata
Record added

[Prophylactic use of icatibant before tracheal intubation of a patient with hereditary angioedema type III. (A literature review of perioperative management of patients with hereditary angioedema typ…

PubMed lists PMID 24931134 in Revista espanola de anestesiologia y reanimacion as Case Reports, Journal Article, Review, with publication-date metadata of 2014-06-13 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 30, 2016
Evidence lane
Literature metadata
Record added

Icatibant as acute treatment for hereditary angioedema in adults.

PubMed lists PMID 27123689 in Expert review of clinical pharmacology as Journal Article, Review, with publication-date metadata of 2016-05-13 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 10, 2017
Evidence lane
Literature metadata
Record added

Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B2 Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast Cells.

PubMed lists PMID 30651343 in Journal of immunology (Baltimore, Md. : 1950) as Journal Article, Research Support, N.I.H., Extramural, with publication-date metadata of 2019-01-16 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 9, 2020
Evidence lane
Literature metadata
Record added

The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient icatibant.

PubMed lists PMID 30849486 in European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences as Journal Article, with publication-date metadata of 2019-03-06 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 23, 2019
Evidence lane
Literature metadata
Record added

Angioedema by MDMA mediated by bradykinin. Role of icatibant acetate.

PubMed lists PMID 32107042 in Medicina clinica as Letter, with publication-date metadata of 2020-02-24 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 14, 2021
Evidence lane
Literature metadata
Record added

Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.

PubMed lists PMID 32919903 in Allergology international : official journal of the Japanese Society of Allergology as Journal Article, Review, with publication-date metadata of 2020-09-09 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 3, 2021
Evidence lane
Literature metadata
Record added

Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case Report.

PubMed lists PMID 33275101 in Journal of investigational allergology & clinical immunology as Case Reports, Journal Article, with publication-date metadata of 2020-12-04 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Review of icatibant use in the Winnipeg Regional Health Authority.

PubMed lists PMID 33292436 in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology as Journal Article, with publication-date metadata of 2020-11-11 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 30, 2024
Evidence lane
Literature metadata
Record added

Real-world off-label use of icatibant for acute management of non-hereditary angioedema.

PubMed lists PMID 33738947 in Internal medicine journal as Journal Article, with publication-date metadata of 2021-03 (month precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 31, 2021
Evidence lane
Literature metadata
Record added

Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema.

PubMed lists PMID 33851451 in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-05-11 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 4, 2021
Evidence lane
Literature metadata
Record added

Exceptional treatment of COVID-19 pneumonia with icatibant.

PubMed lists PMID 35275476 in Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias as Journal Article, with publication-date metadata of 2022-04 (month precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 30, 2025
Evidence lane
Literature metadata
Record added

How satisfactory is on-demand icatibant from the patients' perspective in real life?

PubMed lists PMID 35317892 in Allergy and asthma proceedings as Journal Article, with publication-date metadata of 2022-03-01 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 18, 2022
Evidence lane
Literature metadata
Record added

In vivo near-infrared fluorescence and SPECT-CT imaging of colorectal Cancer using the bradykinin B2R-specific ligand icatibant.

PubMed lists PMID 36641883 in Journal of photochemistry and photobiology. B, Biology as Journal Article, with publication-date metadata of 2023-01-10 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Icatibant in viral infections.

PubMed lists PMID 37067851 in Infectious diseases (London, England) as Letter, Comment, with publication-date metadata of 2023-04-17 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Assessing the performance of new chromatographic technologies for the separation of peptide epimeric impurities: the case of Icatibant.

PubMed lists PMID 38142950 in European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences as Journal Article, with publication-date metadata of 2023-12-22 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Pathophysiology of COVID-19: A Post Hoc Analysis of the ICAT-COVID Clinical Trial of the Bradykinin Antagonist Icatibant.

PubMed lists PMID 40559541 in Pathogens (Basel, Switzerland) as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2025-05-27 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 27, 2025
Evidence lane
Literature metadata
Record added

Icatibant Acts as a Balanced Ligand of MRGPRX2 in Human Skin Mast Cells.

PubMed lists PMID 41008531 in Biomolecules as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-25 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 29, 2026
Evidence lane
Literature metadata
Record added

Icatibant Use During Pregnancy: A South African Case Series.

PubMed lists PMID 41133754 in Journal of investigational allergology & clinical immunology as Journal Article, with publication-date metadata of 2025-10-24 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 16, 2025
Evidence lane
Literature metadata
Record added

First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib.

PubMed lists PMID 42219034 in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases as Journal Article, Case Reports, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 20, 2026
Evidence lane
Literature metadata
Record added

Icatibant for acute hereditary angioedema attacks in pediatric patients: A systematized review.

PubMed lists PMID 42343494 in Allergy and asthma proceedings as Journal Article, Systematic Review, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 30, 2026
Evidence lane
Literature metadata
Record added

On-demand treatment of icatibant in a patient of hereditary angioedema with KNG1 mutation.

PubMed lists PMID 42656409 in Genes & diseases as Editorial, with publication-date metadata of 2026-05-14 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 28, 2026
Evidence lane
Literature metadata